Back pain, plantar pain, tendinitis…
Far from being mild, these disorders, when poorly treated, can quickly become chronic and have a lasting impact on the daily lives of French people. In order to provide a relevant solution to these pathologies, Epitact®, a French laboratory present in 14 countries, has from the outset placed innovation at the heart of its DNA in the field of podiatry and orthopedics, for the well- to be patient. Through a disruptive approach led by its R&D department at the forefront of innovation, Epitact® has been able to put technology at the service of care by offering products adapted to the muscular and joint pathologies concerned.
Activity orthopedics: a public health issue that is still too underestimated
Technological innovation at the heart of the group’s DNA
Putting movement back at the heart of care priorities